De-Yang Yao

Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(iii) complexes† †Electronic supplementary information (ESI) available: Experimental procedures, figures and tables, references and X-ray crystallographic data. CCDC 1452036–1452038. For ESI and cryst

L. Ji, Z. Mao, Cai-Ping Tan, 2016, Chemical science.

Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial

G. Lou, Junying Tang, Youzhong Zhang, 2021, Gynecologic Oncology.

An immune-associated ten-long noncoding RNA signature for predicting overall survival in cervical cancer

De-Yang Yao, Shengkang Dai, 2021, Translational cancer research.